India’s benchmark indices wrapped up the week on a flat note, showing clear signs of indecision as traders struggled to find ...

KBWD offers a high 12.6% yield via REITs and BDCs but carries high risk, steep fees, and weak long-term returns. Find out why ...

The company faces a key hurdle when Netflix reports its second-quarter results after market close on July 17. Given the stock ...

Palantir bulls point to this as a reason why the stock could reach a $1 trillion valuation by 2035. However, the bears have ...

One of the most popular AI stocks in the market is Palantir Technologies ( PLTR 1.62%). Palantir delivered excellent returns ...

The Alpha Picks portfolio gains amid a ‘Big Beautiful’ week for the markets. Read Alpha Picks’ recap for the week ending ...

BOK Financial faces mixed loan growth prospects, modest 3% EPS growth, and limited upside despite NIM expansion and a 2.2% ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

The U.S. stock market is entering the second half of 2025 with significant momentum. After a volatile start to the year, ...

When it comes to which "Magnificent Seven" stock is the best to buy, I think the answer is clear: Alphabet (GOOGL 0.54%) ...

Artificial intelligence (AI) is a leading growth driver for many companies, but they benefit from AI in different ways.

Travere Therapeutics, Inc. (NASDAQ:TVTX) is one of the 13 Best Pharma Stocks to Buy According to Wall Street Analysts.